[1. Atkinson V. Recent advances in malignant melanoma. Intern Med J 2017; 47(10):1114–21.10.1111/imj.1357428994264]Search in Google Scholar
[2. Longvert C, Saiag P. Melanoma update. Rev Med Interne 2019; 40(3): 178–83.10.1016/j.revmed.2018.11.00530527396]Search in Google Scholar
[3. Cabrera R, Recule F. Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings. Am J Clin Dermatol 2018; 1: 15–23.10.1007/s40257-018-0373-6624463530374898]Search in Google Scholar
[4. Pavri SN, Clune J, Ariyan S, Narayan D. Malignant melanoma: beyond the basics. Plast Reconstr Surg 2016; 138(2): 330e–340e.10.1097/PRS.000000000000236727465194]Search in Google Scholar
[5. Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: from pathogenesis to therapy. Int J Oncol. 2018; 52: 1071–80.10.3892/ijo.2018.4287584339229532857]Search in Google Scholar
[6. Hartman RI, Lin JY. Cutaneous melanoma-a review in detection, staging, and management. Hematol Oncol Clin North Am 2019; 33(1): 25–38.10.1016/j.hoc.2018.09.00530497675]Search in Google Scholar
[7. Iglesias-Pena N, Paradela S, Tejera-Vaquerizo A, Boada A, Fonseca E. Cutaneous melanoma in the elderly: review of a growing problem. Actas Dermosifiliogr 2019; 110: 434–47.10.1016/j.ad.2018.11.00931101317]Search in Google Scholar
[8. Takano T. Natural history of thyroid cancer. Endocr J 2017; 64: 237–44.10.1507/endocrj.EJ17-002628154351]Search in Google Scholar
[9. Luzón-Toro B, Fernández RM, Villalba-Benito L, Torroglosa A, Antiñolo G, Borrego S. Influencers on thyroid cancer onset: molecular genetic basis. Genes (Basel) 2019; 10: 913.10.3390/genes10110913689580831717449]Search in Google Scholar
[10. Albi E, Cataldi S, Lazzarini A, Codini M, Beccari T, Ambesi-Impiombato FS, et al. Radiation and Thyroid Cancer. Int J Mol Sci 2017; 18: 911.10.3390/ijms18050911545482428445397]Search in Google Scholar
[11. Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol 2018; 14: 670–83.10.1038/s41574-018-0080-730131586]Search in Google Scholar
[12. Ferrari SM, Fallahi P, Elia G, Ragusa F, Ruffilli I, Paparo SR, et al. Thyroid autoimmune disorders and cancer. Semin Cancer Biol 2020; 64: 135–46.10.1016/j.semcancer.2019.05.01931158464]Search in Google Scholar
[13. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010; 174: 741–5210.1667/RR2240.1308002321128798]Search in Google Scholar
[14. Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol 2012; 19: 1887–96.10.1245/s10434-011-2193-2437219522227921]Search in Google Scholar
[15. Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018; 18: 269–82.10.1038/nrc.2018.1129497144]Search in Google Scholar
[16. Hahn LD, Kunder CA, Chen MM, Orloff LA, Desser TS. Indolent thyroid cancer: knowns and unknowns. Cancers Head Neck 2017; 2: 1.10.1186/s41199-016-0021-x646073231093348]Search in Google Scholar
[17. Serafini MS, Lopez-Perez L, Fico G, Licitra L, De Cecco L, Resteghini C. Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures. Cancers Head Neck 2020; 5: 2.10.1186/s41199-020-0047-y697187131988797]Search in Google Scholar
[18. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 2017; 112: 136–52.10.1016/j.critrevonc.2017.01.01928325255]Search in Google Scholar
[19. Nenclares P, Ap Dafydd D, Bagwan I, Begg D, Kerawala C, King E, et al. Head and neck mucosal melanoma: The United Kingdom national guidelines. Eur J Cancer 2020; 138: 11–18.10.1016/j.ejca.2020.07.01732829104]Search in Google Scholar
[20. Green B, Elhamshary A, Gomez R, Rahimi S, Brennan PA. An update on the current management of head and neck mucosal melanoma. J Oral Pathol Med 2017; 46: 475–79.10.1111/jop.1252627864904]Search in Google Scholar
[21. Jaballah Vinckenbosch P, Litzistorf Y, Gaide O, Özdemir BC, Michielin O, Reinhard A. ENT management of head and neck cutaneous melanoma. Rev Med Suisse 2020; 16: 1853–59.]Search in Google Scholar
[22. Lerner BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal melanoma: new insights and therapeutic options for a unique and aggressive disease. Oncology 2017; 31: e23–e32.]Search in Google Scholar
[23. Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012; 5: 739-53.]Search in Google Scholar
[24. Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, et al. Papillary thyroid cancer- aggressive variants and impact on management: a narrative review. Adv Ther 2020; 37: 3112–28.10.1007/s12325-020-01391-1746741632488657]Search in Google Scholar
[25. Haroon Al Rasheed MR, Xu B. Molecular alterations in thyroid carcinoma. Surg Pathol Clin 2019; 12: 921–30.10.1016/j.path.2019.08.002688392331672298]Search in Google Scholar
[26. Costa MM, Belo S, Capela-Costa J, Costa J, Carvalho D. Malignant melanoma with synchronous thyroid metastases: case report and literature review. Arch Endocrinol Metab 2017; 61: 193–97.10.1590/2359-399700000025128225857]Search in Google Scholar
[27. Heroiu Cataloiu AD, Danciu CE, Popescu CR. Multiple cancers of the head and neck. Maedica (Bucur) 2013; 8 : 80–85.]Search in Google Scholar
[28. Miccoli P, Bakkar S. Surgical management of papillary thyroid carcinoma: an overview. Updates Surg. 2017; 69:145–50.10.1007/s13304-017-0449-528405952]Search in Google Scholar